iBio, Inc. (IBIO)
NASDAQ·Healthcare·Biotechnology
$1.47
+3.17%
Mkt Cap $21.95M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (2 analysts)
$2.80
Range $2.00 – $3.60
Implied Upside
+91.1%
Consensus $2.80 vs current $1.47
NASDAQ·Healthcare·Biotechnology
$1.47
+3.17%
Mkt Cap $21.95M
Buy
4
Hold
0
Sell
0
Price Target (2 analysts)
$2.80
Range $2.00 – $3.60
+91.1%
Consensus $2.80 vs current $1.47